{"id":2863,"date":"2020-03-25T09:15:00","date_gmt":"2020-03-25T09:15:00","guid":{"rendered":"https:\/\/www.xvivogroup.com\/us\/mfn_news\/the-nomination-committee-proposes-unchanged-board-remuneration\/"},"modified":"2020-03-25T09:15:00","modified_gmt":"2020-03-25T09:15:00","slug":"the-nomination-committee-proposes-unchanged-board-remuneration","status":"publish","type":"mfn_news","link":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/the-nomination-committee-proposes-unchanged-board-remuneration\/","title":{"rendered":"The Nomination Committee proposes unchanged Board remuneration"},"content":{"rendered":"<p><span><span><span>Due to the situation with the corona pandemic, XVIVO Perfusion&#39;s Nomination Committee has decided to withdraw the proposal that XVIVO Perfusion&#39;s Annual General Meeting on March 31, 2020 approves an increase in Board remuneration (item 12 on the agenda). Instead, the Nomination Committee proposes unchanged Board remuneration compared to 2019. The Nomination Committee&#39;s other proposals for the Annual General Meeting remain unchanged.<\/span><\/span><\/span><\/p>\n<div class=\"mfn-footer\">\n<p><span><span>For further information please contact:<\/span><\/span><\/p>\n<p><span><span>Christoffer Rosenblad, CFO, +46 735 192159, christoffer.rosenblad@xvivoperfusion.com<br \/>\nMagnus Nilsson, CEO, +46 31 788 2150, magnus.nilsson@xvivoperfusion.com<\/span><\/span><br \/>\n<span><span>For further information on XVIVO Perfusion\u2019s business, please refer to the company\u2019s website, www.xvivoperfusion.com<\/span><\/span><\/p>\n<p><span><span>This information is information that Xvivo Perfusion AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation.\u00a0\u00a0The information was submitted for publication, through the agency of the contact person set out above, at 10:15\u00a0am CET on March 25, 2020.<\/span><\/span><\/p>\n<p><span><span>This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.<\/span><\/span><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Due to the situation with the corona pandemic, XVIVO Perfusion&#39;s Nomination Committee has decided to withdraw the proposal that XVIVO&#8230;<\/p>\n","protected":false},"template":"","class_list":["post-2863","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn","mfn-news-tag-mfn-type-ir","mfn-news-tag-mfn-lang-en","mfn-news-tag-mfn-regulatory","mfn-news-tag-mfn-regulatory-mar","mfn-news-tag-mfn-ci","mfn-news-tag-mfn-ci-other"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>The Nomination Committee proposes unchanged Board remuneration - XVIVO<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/the-nomination-committee-proposes-unchanged-board-remuneration\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The Nomination Committee proposes unchanged Board remuneration - XVIVO\" \/>\n<meta property=\"og:description\" content=\"Due to the situation with the corona pandemic, XVIVO Perfusion&#039;s Nomination Committee has decided to withdraw the proposal that XVIVO...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/the-nomination-committee-proposes-unchanged-board-remuneration\/\" \/>\n<meta property=\"og:site_name\" content=\"United States\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/the-nomination-committee-proposes-unchanged-board-remuneration\\\/\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/the-nomination-committee-proposes-unchanged-board-remuneration\\\/\",\"name\":\"The Nomination Committee proposes unchanged Board remuneration - XVIVO\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\"},\"datePublished\":\"2020-03-25T09:15:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/the-nomination-committee-proposes-unchanged-board-remuneration\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/the-nomination-committee-proposes-unchanged-board-remuneration\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/the-nomination-committee-proposes-unchanged-board-remuneration\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"The Nomination Committee proposes unchanged Board remuneration\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\",\"name\":\"United States\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The Nomination Committee proposes unchanged Board remuneration - XVIVO","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/the-nomination-committee-proposes-unchanged-board-remuneration\/","og_locale":"en_US","og_type":"article","og_title":"The Nomination Committee proposes unchanged Board remuneration - XVIVO","og_description":"Due to the situation with the corona pandemic, XVIVO Perfusion&#39;s Nomination Committee has decided to withdraw the proposal that XVIVO...","og_url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/the-nomination-committee-proposes-unchanged-board-remuneration\/","og_site_name":"United States","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/the-nomination-committee-proposes-unchanged-board-remuneration\/","url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/the-nomination-committee-proposes-unchanged-board-remuneration\/","name":"The Nomination Committee proposes unchanged Board remuneration - XVIVO","isPartOf":{"@id":"https:\/\/www.xvivogroup.com\/us\/#website"},"datePublished":"2020-03-25T09:15:00+00:00","breadcrumb":{"@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/the-nomination-committee-proposes-unchanged-board-remuneration\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.xvivogroup.com\/us\/pressreleases\/the-nomination-committee-proposes-unchanged-board-remuneration\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/the-nomination-committee-proposes-unchanged-board-remuneration\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.xvivogroup.com\/us\/"},{"@type":"ListItem","position":2,"name":"The Nomination Committee proposes unchanged Board remuneration"}]},{"@type":"WebSite","@id":"https:\/\/www.xvivogroup.com\/us\/#website","url":"https:\/\/www.xvivogroup.com\/us\/","name":"United States","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.xvivogroup.com\/us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news\/2863","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/media?parent=2863"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}